Fig. 7.

Impact of ONX 0914 treatment on T cell responses. Age and gender matched A/J mice were infected with CV Nancy. Starting on day 3, CV infected mice were either treated with the vehicle Captisol^® or with 10 mg/kg BW ONX 0914 daily (n = 10 per group) and mice were analysed on day 8. The data reflect cardiac a and splenic b mRNA expression levels, as determined by qPCR in each group (n = 10) and normalized to vehicle ( = 5) and nONX 0914-treated control groups (n = 6). Data is summarized as mean ± SEM